Innovation Pathway aims to reduce time and cost of bringing safe and effective, breakthrough technologies to patients
Silver Spring, Maryland–(ENEWSPF)–April 9, 2012. Three products for patients with end stage renal disease (ESRD) have been chosen to participate in the FDA’s Innovation Pathway, an evolving system designed to help medical devices reach patients in a safe, timely and collaborative manner.
The FDA selected three from 32 product applications ranging from an artificial kidney to devices that…
